Loading... please wait
Lazarex - Lazarex Cancer Foundation

Lazarex Cancer Foundation


Concordia is partnering with Lazarex Cancer Foundation, a non-profit focused on improving patient access to cancer clinical trials, with the ultimate goal of ensuring that patients are able to undergo the most advanced and innovative cancer treatments.

This year-round programming partnership will provide a platform to spread awareness about the importance of—and barriers to—expanding patient access to clinical trials through increased participation, minority enrollment, and retention. It will also engage a multi-sector audience, including key stakeholders and policy makers, to ensure a continued commitment to finding sustainable solutions to accelerating cancer research.

At Concordia, our Global Health & Emergency Response Programming Pipeline focuses on issues ranging from international epidemics and equitable health access to global aid delivery and natural disaster preparedness. Within this pipeline, a key issue for our Members, Advisors, and Partners is the need to advance collaborative cancer research.

Making cancer treatments accessible and affordable remains one of the biggest challenges of today. Lazarex’s work to create an even playing field for all patients has resulted in the FDA issuing official guidance earlier this year to reimburse patients for travel expenses relating to clinical trials, therefore allowing all cancer patients access to potentially life-saving treatments.

While this new FDA guidance opens the door to new pathways and discussions, it is critical that all actors have a seat at the table in order to establish collaborative, lasting solutions. With this in mind, Concordia’s programming partnership with Lazarex will look to bring together thought leaders in oncology and healthcare to spark critical discussions around the outlook for cancer treatment across the world. Convening lawmakers, government representatives, and pharmaceutical companies, we will explore how to prompt policy and action to increase clinical trial participation and improve cancer survivability rates, regardless of a patient’s ability to pay.

To read more about this programming partnership, please visit www.concordia.net/newsroom/blog/qa-with-lazarex

To learn more about Lazarex, please visit Lazarex.org

To learn more about the 2018 Concordia Annual Summit, please visit www.concordia.net/annualsummit/2018annualsummit